These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2441487)

  • 1. A human monoclonal antibody against HLA-A25.
    Kosinski S; Ferrara GB; Yang SY; Hämmerling U
    Tissue Antigens; 1987 Apr; 29(4):177-83. PubMed ID: 2441487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro production of a human HLA alloantibody of restricted specificity (DQw2) via Epstein-Barr virus transformation.
    Pistillo MP; Hämmerling U; Dupont B; Ferrara GB
    Hum Immunol; 1986 Jan; 15(1):109-17. PubMed ID: 2419282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal antibody against HLA-A11 and A24.
    Foung SK; Taidi B; Ness D; Grumet FC
    Hum Immunol; 1986 Mar; 15(3):316-9. PubMed ID: 2420768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody against HLA-Aw32 + A25. Is HLA-Aw32 an allele with no unique antigenic determinant?
    Vilella R; Yague J; Vives J
    Hum Immunol; 1983 Jan; 6(1):53-62. PubMed ID: 6187719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen.
    Wallace LE; Rickinson AB; Rowe M; Epstein MA
    Nature; 1982 Jun; 297(5865):413-5. PubMed ID: 6176881
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G; Rickinson AB
    Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
    Yannelli JR; Moore LC; Engelhard VH
    J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a human hybridoma producing a pure anti-HLA-A2 monoclonal antibody.
    Wallace EF; Foung SK; Bradbury K; Pask SL; Grumet FC
    Hum Immunol; 1990 May; 28(1):65-9. PubMed ID: 2160447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Branhamella catarrhalis activates human B lymphocytes following interactions with surface IgD and class I major histocompatibility complex antigens.
    Forsgren A; Penta A; Schlossman SF; Tedder TF
    Cell Immunol; 1988 Mar; 112(1):78-88. PubMed ID: 2449982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants.
    Wallace LE; Moss DJ; Rickinson AB; McMichael AJ; Epstein MA
    Eur J Immunol; 1981 Sep; 11(9):694-9. PubMed ID: 6271557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening a hybridoma producing a specific monoclonal antibody to HLA-A24+Bw4 antigen by cytotoxicity inhibition assay.
    Hiroishi S; Kaneko T; Arita J
    Tissue Antigens; 1987 Feb; 29(2):120-2. PubMed ID: 3299870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-cell hybrids with HLA-restricted proliferative response to Epstein-Barr virus-infected B cells.
    Gallagher G; Stimson WH
    Immunology; 1984 Dec; 53(4):611-21. PubMed ID: 6209205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T cell receptor-mediated recognition of HLA-E.
    García P; Llano M; de Heredia AB; Willberg CB; Caparrós E; Aparicio P; Braud VM; López-Botet M
    Eur J Immunol; 2002 Apr; 32(4):936-44. PubMed ID: 11920559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen.
    Gaston JS; Rickinson AB; Epstein MA
    J Exp Med; 1983 Aug; 158(2):280-93. PubMed ID: 6193217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
    Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody recognizing a determinant common to HLA-A3 and A11.
    Billing R; Clark B; Lucero K; Shi BJ; Terasaki P
    Tissue Antigens; 1982 Feb; 19(2):121-8. PubMed ID: 6179256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein A binding assay for the identification of HLA antigens on peripheral blood lymphocytes by monoclonal antibodies: application to HLA B27.
    Yang YH; Grumet FC; Fendly B; Engleman E; Shively JE
    Hybridoma; 1982; 1(3):243-55. PubMed ID: 6208127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro.
    Moss DJ; Wallace LE; Rickinson AB; Epstein MA
    Eur J Immunol; 1981 Sep; 11(9):686-93. PubMed ID: 6170517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants.
    Gaston JS; Rickinson AB; Epstein MA
    J Exp Med; 1983 Dec; 158(6):1804-21. PubMed ID: 6196431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.